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Mice that lack the extracellular matrix protein observed, but thrombospondin 2-null epithelia formed
rete pegs and were thicker than control epithelia. Bythrombospondin 2 have, among several abnormali-
immunohistochemistry, we detected elevated levelsties, an increase in vascular density, abnormal
and an irregular deposition pattern for fibronectincollagen fibrils, and dermal fibroblasts that are
in thrombospondin 2-null wounds, observations thatdefective in adhesion. These findings suggested that
correlated with the abnormal collagen organization inresponses involving these processes, such as wound
the granulation tissue. Immunostaining for thrombo-healing, might be altered. To investigate the healing
spondin 2 in control wounds showed that the proteinprocess, excisional wounds were made with the aid
is present in both early and late wounds, in a scatteredof a biopsy punch. Such wounds, observed over a cell-associated pattern or widely distributed cell- and14 d period, appeared to heal at an accelerated rate matrix-associated pattern, respectively. Our results
and with less scarring in thrombospondin 2-null suggest that thrombospondin 2 plays a crucial part
mice. Histologic analysis of thrombospondin 2-null in the organization and vascularization of the granula-
wound sites revealed the presence of an irregularly tion tissue during healing, possibly by modulating
organized and highly vascularized granulation tissue. fibroblast–matrix interactions in early wounds and
In addition, thrombospondin 2-null wounds retained regulating the extent of angiogenesis in late wounds.
a higher total cellular content, than control wounds. Key words: angiogenesis/fibrillogenesis/matricellular/re-
modeling. J Invest Dermatol 113:782–787, 1999No differences in wound re-epithelization rates were
T when cultured in vitro demonstrated an adhesion defect. Theseobservations suggested that TSP2 has important roles in theformation of collagen fibrils, in the interaction of cells with theECM, and in the vascularization of tissues.Recently, we observed that following the subcutaneoushrombospondin 2 (TSP2) is a member of a proteinfamily that is comprised of five secreted modularglycoproteins (TSP 1–5; Frazier, 1991; Bornstein,1992; Adams and Lawler, 1993; Bornstein and Sage,1994). It is thought that these proteins are multi-
implantation of silicone disks in TSP2-null mice, the resultingfunctional components of the extracellular matrix (ECM) that can
foreign body capsules were highly vascularized, and containedmodulate cell–matrix interactions (Bornstein, 1995). Their biologic
irregularly shaped collagen fibers (Kyriakides et al, 1999). Theseroles, however, are poorly understood. TSP2, like its structural
observations corroborated several aspects of the phenotype andhomolog TSP1 (Good et al, 1990; Tolsma et al, 1993) has been
suggested that the tendency for these abnormalities to developshown to modulate the activity of basic fibroblast factor on
persisted in adult TSP2-null mice. As the formation of foreignendothelial cells and to inhibit angiogenesis (Volpert et al, 1995).
body capsules involves many of the processes that make up theTSP2 mRNA and protein have been detected in mouse embryos
wound healing response (Woodward, 1982; Williams, 1989; Tangpredominantly in connective tissues such as dermis, tendon, and
and Eaton, 1995) we hypothesized that the latter may also beligaments (Iruela-Arispe et al, 1993; Kyriakides et al, 1998a; Tooney
altered in TSP2-null mice.et al, 1998). A structural role for TSP2 in these tissues has not been
To investigate the healing response, wounds were made on thedemonstrated. In adult mice, the distribution of TSP2 is limited
backs of TSP2-null and control mice with the aid of a biopsyand is associated predominantly with cells such as the skin fibroblasts
punch, and the gross and histologic appearance of the wounded(Kyriakides et al, 1998a). Consistent with its distribution pattern
areas was observed for a period of 14 d. Wound tissue was alsoand anti-angiogenic activity, disruption of the Thbs2 gene in mice
harvested and processed for histologic analysis at selected time pointsresulted in the development of a pleiotropic phenotype that
post-wounding. The total cellularity, vascularity, and appearance ofincluded aberrations in collagen fibrillogenesis and angiogenesis,
the granulation tissue and regenerating epithelium were examined.findings which were more prominent in tissues such as skin
In addition, we performed immunohistochemical analysis of the(Kyriakides et al, 1998b). In addition, TSP2-null skin fibroblasts
deposition of fibronectin, a component of the ECM that participates
in wound healing. Control wound sections were also analyzed by
immunohistochemistry to determine the spatiotemporal distributionManuscript received April 1, 1999; revised July 13, 1999; accepted for
of TSP2. This study provides evidence for expression of TSP2publication August 5, 1999.
during the wounding response. Our results suggest that TSP2Reprint requests to: Dr. Paul Bornstein, Department of Biochemistry,
performs a number of important functions during wound healingBox 357350, University of Washington, Seattle, WA 98195, U.S.A.
Abbreviation: TSP, thrombospondin. but that, surprisingly, its absence may lead to improved healing.
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MATERIALS AND METHODS
Mice Three month old 129SV/J age-matched wild-type and TSP2-null
mice, generated by gene targeting (Kyriakides et al, 1998b), were used in
this study. All wounded mice were housed individually. A total of three
mice/genotype/time point, and two wounds/mouse were utilized.
Wounds Excisional wounds were made with the aid of 6 mm punches
(Acuderm, Ft Lauderdale, FL) essentially as described by Subramaniam et al
(1997), with the only exception that Avertin (Aldrich, Milwaukee, WI)
was used for anesthesia. At selected time points, mice were killed and
wounds were harvested with a rim of approximately 2 mm of unwounded
tissue. A mark was made on the top left corner of each excised wound for
orientation.
Processing and staining Wound tissues were sandwiched in porous
holders to prevent them from curling, fixed in 10% formalin (Z-fix,
Anatech, Battle Creek, MI), processed, cut in half, and embedded in
paraffin. To reduce variability during cutting and embedding, wounds
were laid flat and cut with a single edge razor blade placed vertically over
the middle of the wound. The two resulting pieces were placed in paraffin
wound-face down and were kept vertical until the paraffin hardened. Five
micrometer sections were stained with hematoxylin and eosin (H&E) as
Figure 1. Excisional wounds heal at an accelerated rate in TSP2-described previously (Kyriakides et al, 1998a). To visualize nuclei, sections
null mice. One week after the creation of a full thickness wound, wild-were stained with 5 µg per ml DAPI (Sigma, St Louis, MO) in 1% bovine
type mice retained a substantial scab (left mouse in a) whereas the scabserum albumin, 0.01% Triton X-100. To visualize red blood cells, which
had detached in the TSP2-null mice (right mouse in a). Close up viewsautofluoresce, sections were deparaffinized and rehydrated and examined
of day 10 wounds in a wild-type (b) and TSP2-null (c) animal. Thewith the aid of fluorescence optics. A Nikon Eclipse 800 microscope
latter has a wound without a scab, and with reduced inflammation andequipped with fluorescence optics was used for all examinations.
little scarring.
Immunohistochemistry Immunolocalization of TSP2 was performed
with two rabbit anti-TSP2 antibodies as described previously (Kyriakides
et al, 1998a). All of the data shown were obtained with a polyclonal
antibody made against the full-length TSP2 molecule; similar results were superficial signs of inflammation and retained a visible scar (data
obtained with a polyclonal antibody against the amino-terminal domain of not shown).
TSP2. Identical procedures were followed for the detection of TSP1 (with Examination of H&E-stained sections of wounds revealed
a rabbit anti-mouse TSP1 antibody, a kind gift of Dr. D. Mosher, University dramatic differences in the behavior of the regenerating
of Wisconsin, Madison, WI) and fibronectin (with a rabbit anti-fibronectin epithelium, with the formation of characteristic rete pegs (epidermalantibody, Sigma). Immunolocalization for PECAM-1 (CD31) was per-
invaginations into the dermis) in day 7 wounds of TSP2-null miceformed as described above except that tissues were treated with 0.025%
(Fig 2b). The rete pegs, which were most obvious between daystrypsin/pronase for 30 min at 37°C prior to blocking, according to the
5 and 8, were absent from control animals at all time points, andsupplier’s (Pharmingen, San Diego, CA) instructions. The antibody (clone
disappeared from TSP2-null animals by day 10. The regeneratingMEC 13.3) was applied to tissues at a concentration of 10 µg per ml.
epithelium of null animals was also thicker during the same interval
(Fig 3). The difference in thickness diminished by day 14 (dataQuantitation A digital camera was used to capture a series of images
from sections stained with DAPI and a grid was placed over the images to not shown). Wounds of both TSP2-null and control animals
enable the estimation of the number of nuclei per unit area. Estimation of retained similar levels of inflammatory cells throughout healing (see
epithelial thickness was performed on H&E-stained sections with the aid Fig 2 for day 10 wounds). The organization of the granulation
of an ocular micrometer. For each section, measurements were taken at tissue in the remodeling phase, day 14, however, was markedly
the two edges of the wound and, depending on length, one or more different between control (Fig 4a) and TSP2-null animals (Fig 4b)measurements were taken from the middle of the wound. Areas of
with the latter having collagen fibers that lacked the extensiveepidermal invagination (rete pegs) were not included in the measurements.
parallel orientation seen in controls. Rather, collagen fibers inEstimation of wound neovascularization was performed by counting
mutant wounds were organized in a basket-weave fashion thatPECAM-1-positive figures within granulation tissue. Slides were labeled
resembled, somewhat, the appearance of uninjured dermis. Thiswith a code and a series of digital images from the center of each wound
was generated. Two investigators counted the number of blood vessels in organization may account for the more diffuse deposition pattern
each image and the files were then renamed and counted again. The of fibronectin in these animals at this time point (see Fig 7b).
collected data revealed insignificant variation between the repeat measure- Differences in the vascularity of granulation tissue were also
ments and the measurements of the two investigators. evident. Sections examined with the aid of fluorescence optics
revealed the presence of a significantly higher number of redRESULTS blood cells in TSP2-null mice in the later phases (days 10–14) of
the healing process (data not shown). This observation was alsoGross and histologic appearance of healing wounds Wounds
of TSP2-null mice were indistinguishable from control wounds up made in H&E-stained sections but was not as easily demonstrable.
Immunolocalization of endothelial cells with anti-PECAM-1 anti-to day 5. On this day some null animals had lost the wound scab.
By day 7, most TSP2-null mice had wounds without a scab, bodies permitted a more direct evaluation of wound neo-
vascularization. Representative sections are shown in Fig 5(a, b).whereas control animals retained their scabs for 2 more days
(Fig 1a). Knockout animals examined on day 10 showed a Quantitation of blood vessels, shown in Fig 5(c), demonstrated the
prolonged neovascularization of TSP2-null wounds. Unlike controlsignificant improvement in the overall appearance of the wound,
with reduced inflammation as indicated by reduced redness, and wounds in which a decrease in vascularization occurs with time,
TSP2-null wounds remain highly vascularized over the observedminimal scarring (Fig 1c). In contrast, control animals either
retained a portion of the scab, or had shed it but exhibited a period. Attempts to visualize the vascular endothelium with anti-
von Willebrand factor antibodies were unsuccessful. As bloodscarred, inflamed wound (Fig 1b). By day 14, wounds of the
TSP2-null animals were not easily visible as they exhibited no vessels in uninjured dermis adjacent to the wound site stained
positive for von Willebrand factor we conclude that endothelialredness and minimal scarring. Control animals showed a significant
improvement in healing, but their wounds still demonstrated cells in healing wounds do not express this factor. Consistent with
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Figure 2. Abnormal re-epithelializa-
tion of day 7 TSP2-null wounds. Sec-
tions of day 7 wounds were stained with
H&E. The epithelium covering control
wounds (a) remained flat over the wound
bed. On the contrary, in TSP2-null wounds
(b) the newly formed epithelium invaded
the granulation tissue to form rete pegs
(arrows). Arrowhead in (b) denotes an area
with a high local concentration of inflam-
matory and red blood cells. Scale bar:
100 µm.
Figure 3. Wound epithelium thickness is increased in day 7 TSP2-
null mice. H&E-stained day 7 wound sections were analyzed for the
thickness of the newly formed epithelial layer with the aid of an ocular
micrometer. A total of five sections/wound from six wounds, three mice/
genotype were measured. *p , 0.05.
an increase in vascularity, we also observed an increase in the total
cellularity of TSP2-null wounds, which was quantitated following
visualization of nuclei with DAPI (Fig 6). The difference in overall
cellularity was more pronounced in day 10 wounds, but remained
significant through day 14.
Immunohistologic analysis of healing wounds Immuno-
histochemical analysis with an anti-fibronectin antibody showed
that this protein is prominently present in day 14 wounds of both
control (Fig 7a) and TSP2-null (Fig 7b) animals. The immuno-
staining pattern in control wounds appeared punctate and resembled
the organized alignment of the collagen fibers. On the contrary,
the pattern of fibronectin staining in TSP2-null wounds appeared
patchy, a distribution which may reflect the abnormal arrangement
of collagen fibers (see Fig 4d). Examination of sections from several
animals gave us the impression that there was more immunoreaction
product in TSP2-null wounds. A more sophisticated quantitative Figure 4. Abnormal organization of granulation tissue in day 14
method, however, will have to be used to determine the relative wounds. H&E-stained sections of day 14 wounds from control (a) and
fibronectin levels. Differences in the immunostaining patterns of TSP2-null (b) animals. In control wounds collagen fibers were organized
fibronectin at earlier time points (days 7–10) were also observed, in an arrangement parallel to the epidermis. The collagen fibers in TSP2-
null wounds were arranged in a basket-weave fashion and lacked anbut were more subtle (data not shown).
orientation to the epidermis. Scale bar: 50 µm.In control wounds the immunostaining pattern for TSP2 varied
during the course of healing. In day 3 wounds (Fig 8a), the
presence of TSP2 protein was detected only in a small number of
fibroblast-like cells. No matrix-associated staining was observed. In 14, TSP2 protein appeared to decrease, especially in the matrix,
but remained high in cells (arrows in Fig 8d). Low levels of TSP2day 7, 10, and 14 wounds (Fig 8b–d), the presence of TSP2 protein
was prominent, with a greater number of positive fibroblasts and protein, however, could still be detected in some areas of the
matrix. Examination of day 5 wounds showed inconsistent resultssome matrix-associated staining. In day 7 and 10 wounds, the
pattern appeared to be widespread in the wound bed, including with some wounds having patterns that resembled day 3 wounds
and some that resembled day 7 wounds (data not shown). Immuno-areas that were highly vascularized (arrows in Fig 8b, c). By day
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Figure 7. Abnormal pattern of fibronectin deposition in TSP2-null
Figure 5. TSP2-null wounds remain vascularized during remodeling granulation tissue. Sections of day 14 wounds were stained with an anti-
of granulation tissue. Sections of wounds were stained with anti- fibronectin antibody and visualized by the peroxidase reaction. The
PECAM1 antibodies and visualized by the peroxidase reaction. Representa- deposition of reaction product in wild-type wounds (a) appeared in a
tive sections displaying blood vessels within granulation tissue from day 14 punctate pattern (arrows) and was unevenly distributed. In TSP2-null
wounds are shown for a wild-type (a) and a TSP2-null wound (b). Scale wounds (b) the deposition was patchy (arrows), and was prominent through-
bar: 50 µm. (c) Results of vessel quantitation for day 7, 10, and 14 wounds. out the granulation tissue. Scale bar: 100 µm.
A total of 24 sections (area per high power field, 0.04 mm2) from eight
wounds from four animals per time point were quantitated for each
genotype. *p ø 0.05.
staining of TSP2-null wounds, as a negative control, revealed no
specific immunoreactivity (data not shown).
Preliminary immunohistochemical analysis of wounds for TSP1
revealed that this protein is present in the early inflammatory
phase (day 3), but not in the later tissue formation phases (days
7–14). Our observations are generally in agreement with previous
studies that investigated the deposition of TSP1 during healing
(Raugi et al, 1987; DiPietro et al, 1996). Our inability to detect
TSP1 in the late phases of healing, during which it has been
observed in human wounds (Raugi et al, 1987), may reflect
species differences or differences in the sensitivity of the
antibodies. Importantly, we did not observe changes in the
TSP1 immunostaining patterns of control and TSP2-null wounds
(data not shown).
DISCUSSION
The importance of the matricellular protein TSP2 in the processes
of collagen fibrillogenesis and angiogenesis was suggested by the
abnormalities we observed in TSP2-null mice (Kyriakides et al,
1998b); however, the mechanisms by which TSP2 participates in
these processes are not well understood. A number of clues to
possible mechanisms have been gathered from in vivo analysis of
Figure 6. Wounds in TSP2-null mice retain a high total cellular TSP2-null mice. For example, we have observed that following
content during healing. Sections of wounds were stained with DAPI the implantation of solid PDMS (silastic) disks or cube-shaped
and the number of nucleated cells within the granulation tissue was polyvinyl alcohol sponges, TSP2-null mice mount exaggeratedestimated from 15 sections (four mice per genotype, five sections per
fibroplastic and angiogenic responses (Kyriakides et al, 1999;wound).*p , 0.05.
unpublished observations). In the present investigation we examined
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Figure 8. Immunolocalization of
TSP2 in wild-type granulation tissue.
Sections from day 3 (a), day 7 (b), day
10 (c), and day 14 (d) were stained with
an anti-TSP2 antibody and visualized by
the peroxidase method. TSP2 was local-
ized to a few selected cells (arrows in a)
in day 3 wounds. At days 7, 10, and 14,
TSP2 appeared in both cells and the
surrounding matrix (b–d). In day 7 and
10 wounds some of the immunoreactivity
was found in areas that were highly
vascularized (arrows in b and c). In day
14 wounds TSP2 was more prominent
in individual cells (arrows in d) than in
the matrix. No immunoreactivity was
detected in wounds from TSP2-null mice
(data not shown). Scale bars: 50 µm.
whether these abnormalities extended to the remodeling and 1998a; Tooney et al, 1998), and we were unable to detect it in
either the normal or wound epidermis, we found the formation ofneovascularization of healing excisional wounds. As the presence
of TSP2 in the wound healing response had not been demon- rete pegs in TSP2-null wounds surprising. Possibly, the abnormal
structure and composition of the granulation tissue, or increasedstrated, we also performed an immunohistochemical analysis of its
distribution. vascular density, can produce signals that alter the migration and
proliferation patterns of re-epithelializing cells. The finding thatWound healing consists of a series of distinct but overlapping
processes including inflammation, granulation tissue formation, and rete peg formation is absent from late wounds, despite their
prolonged neovascularization, suggests that changes within theremodeling (Clark, 1993; Mutsaers et al, 1997). Key early events
during healing are the invasion of collagen-secreting fibroblasts and granulation tissue can affect the behavior of the newly formed
epithelium. A similar appearance of the epithelium with formationnew vasculature into the wound bed. At this early time (day 3),
deposition of TSP2 was sparse and localized to a small number of of rete pegs is seen in human psoriatic skin lesions. Interestingly,
this condition is believed to be associated with an increase in thecells, believed to be fibroblasts. Later, the response consisted of
processes whose function is to form and then remodel granulation dilatation and tortuosity of the microvasculature, as well as an
increase in total microvasculature (Barton et al, 1992).tissue, also known as provisional matrix, to a state resembling that
of uninjured dermis. During this phase a decrease in the degree of It should be noted that the re-epithelization rate and reduction
of the wound area were indistinguishable between TSP2-null andvascularization, possibly due to regression, was also observed. The
deposition of TSP2 at this time (days 7–14) was pronounced and control animals. The latter observation was unexpected in view of
the fact that TSP2-null dermal fibroblasts do not contract collagenwidespread.
Thus, an association can be made between low levels of TSP2 gels efficiently.1 Collagen gel contraction has been proposed as an
in vitro model for predicting the rate of wound contraction, whichand increased angiogenesis in early wounds, and high levels of
TSP2 and regressing angiogenesis in late wounds. In addition, high is believed to result from the contractile action of myofibroblasts
within the wound bed (Grinnell, 1994; Moulin et al, 1996). Inlevels of TSP2 coincide with granulation tissue formation and
matrix remodeling. These associations are also supported by contrast, Gross et al (1995) have shown that the systematic removal
of granulation tissue does not compromise wound closure; thisobservations made during the healing of wounds in TSP2-null
mice. Consistent with the presence of very few TSP2-positive cells finding suggests that results obtained by the collagen gel contraction
method may not be reliable in predicting the rate of woundin early wounds (days 0–4) in control mice, we were unable to
observe any early abnormalities in the wounds of TSP2-null mice. contraction in vivo. Our observations suggest that, at least for 4 and
6 mm diameter wounds, the inability of TSP2-null dermal fibroblastsThe most prominent alterations in the appearance of wounds in
the latter animals occurred between days 7 and 10, a time to contract collagen gels efficiently does not compromise wound
closure and support the findings of Gross et al (1995). It should becorresponding to maximal TSP2 deposition in control mice.
These associations provide strong circumstantial evidence for the noted, however, that we have not examined granulation tissue
fibroblasts, which may have normal contractile properties. We areparticipation of TSP2 in the wound-healing response.
Wounds in TSP2-null mice appeared to heal at an accelerated currently isolating wound fibroblasts that we will evaluate in the
collagen gel contraction assay.rate as judged by premature loss of the scab and an apparent
reduction in inflammation and scarring. The mechanism leading As expected, we observed abnormally shaped collagen fibers and
a prolonged period of neovascularization in TSP2-null wounds.to this accelerated response is unknown, but the ability of the
epithelium to invade the granulation tissue to form rete pegs and The role of TSP2 in collagen fibrillogenesis has yet to be elucidated.
To date, we have been unable to detect TSP2 as a component ofincrease in thickness may be associated with scab loss. The thickened
epithelium may prevent an adequate visualization of the underlying normal dermis or tendon collagen fibers, and thus we postulate
that TSP2 may function at the cellular level during fibrillogenesis.inflammatory response, which was nevertheless apparent in histo-
logic sections (Fig 2b), and may also account for the improved We have found that TSP2-null fibroblasts have reduced levels of
appearance of the wounds. The lack of organized parallel collagen
fibers, that are the hallmark of a scarred wound (De Vries et al,
1995; Nodder and Martin, 1997), from the wound bed of TSP2- 1Kyriakides TR, Zhu YH, Tam JWY, Zang Z, Bornstein P: Accelerated
null mice may account for the reduced scarring seen in these animals. wound healing in mice with a disruption of the thrombospondin 2 gene.
Mol Biol Cell 9 (Suppl.59a), 1998 (abstr.)As TSP2 is absent from murine epithelial cells (Kyriakides et al,
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(α1 integrin and increased levels of matrix metalloproteinase 2.2 If for technical assistance and Drs May Reed and John Olerud for advice and a critical
reading of the manuscript.and how these alterations affect fibrillogenesis remains to be
determined. Preliminary electron microscopic observations also
revealed that tendon fibroblasts from TSP2-null mice do not
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